Results overview: Found 7 records in 0.02 seconds.
Articles, 4 records found
Research literature, 3 records found
Articles 4 records found  
1.
12 p, 571.6 KB Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus / Torres, Armando (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Hernández, Domingo (Hospital Regional Universitario de Málaga, Universidad de Málaga, IBIMA, Málaga, Spain) ; Moreso, Francesc (Universitat Autònoma de Barcelona. Departament de Medicina) ; Serón, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ; Burgos, María Dolores (Hospital Regional Universitario de Málaga, Universidad de Málaga, IBIMA, Málaga, Spain) ; Pallardó, Luis M. (Hospital Universitario Dr Peset, Valencia, Spain) ; Kanter, Julia (Hospital Universitario Dr Peset, Valencia, Spain) ; Díaz Corte, Carmen (Hospital Universitario Central de Asturias, Oviedo, Spain) ; Rodríguez, Minerva (Hospital Universitario Central de Asturias, Oviedo, Spain) ; Diaz, Juan Manuel (Institut d'Investigació Biomèdica Sant Pau) ; Silva, Irene (Institut d'Investigació Biomèdica Sant Pau) ; Valdes, Francisco (Complexo Hospitalario Universitario Juan Canalejo, A Coruña, Spain) ; Fernández-Rivera, Constantino (Complexo Hospitalario Universitario Juan Canalejo, A Coruña, Spain) ; Osuna, Antonio (Hospital Universitario Virgen de las Nieves, Granada, Spain) ; Gracia Guindo, María C. (Hospital Universitario Virgen de las Nieves, Granada, Spain) ; Gómez Alamillo, Carlos (Hospital Universitario Marqués de Valdecilla, Santander, Spain) ; Ruiz, Juan C. (Hospital Universitario Marqués de Valdecilla, Santander, Spain) ; Marrero Miranda, Domingo (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Pérez-Tamajón, Lourdes (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Rodríguez, Aurelio (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; González-Rinne, Ana (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Alvarez, Alejandra (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Perez-Carreño, Estefanía (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; de la Vega Prieto, María José (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Henriquez, Fernando (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Spain) ; Gallego, Roberto (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Spain) ; Salido, Eduardo (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Porrini, Esteban (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Universitat Autònoma de Barcelona
Despite the high incidence of posttransplant diabetes mellitus (PTDM) among high-risk recipients, no studies have investigated its prevention by immunosuppression optimization. We conducted an open-label, multicenter, randomized trial testing whether a tacrolimus-based immunosuppression and rapid steroid withdrawal (SW) within 1 week (Tac-SW) or cyclosporine A (CsA) with steroid minimization (SM) (CsA-SM), decreased the incidence of PTDM compared with tacrolimus with SM (Tac-SM). [...]
2018 - 10.1016/j.ekir.2018.07.009
Kidney International Reports, Vol. 3 (july 2018) , p. 1304-1315  
2.
15 p, 1.1 MB The Banff 2017 Kidney Meeting Report : Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials / Haas, M. (Cedars-Sinai Medical Center) ; Loupy, A. (University Paris Descartes. INSERM U970 and Necker Hospital. Paris Translational Research Center for Organ Transplantation) ; Lefaucheur, C. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Roufosse, C. (Imperial College London and North West London Pathology) ; Glotz, D. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Serón Micas, Daniel (Hospital Universitari Vall d'Hebron) ; Nankivell, B. J. (Westmead Hospital) ; Halloran, P. F. (University of Alberta) ; Colvin, R. B. (Harvard Medical School. Massachusetts General Hospital) ; Akalin, Enver (Montefiore Medical Center) ; Alachkar, N. (Johns Hopkins University School of Medicine) ; Bagnasco, S. (Johns Hopkins University School of Medicine) ; Bouatou, Y. (Geneva University Hospitals) ; Becker, J. U. (University Hospital of Cologne) ; Cornell, L. D. (Mayo Clinic) ; van Huyen, J. P. Duong (University Paris Descartes. INSERM U970 and Necker Hospital. Paris Translational Research Center for Organ Transplantation) ; Gibson, I. W. (University of Manitoba) ; Kraus, Edward S. (Johns Hopkins University) ; Mannon, R. B. (University of Alabama School of Medicine) ; Naesens, M. (University Hospitals Leuven. University of Leuven & Department of Nephrology) ; Nickeleit, V. (The University of North Carolina School of Medicine) ; Nickerson, P. (University of Manitoba) ; Segev, D. L. (Johns Hopkins Medical Institutions) ; Singh, H. K. (The University of North Carolina School of Medicine) ; Stegall, M. (Mayo Clinic) ; Randhawa, P. (University of Pittsburgh) ; Racusen, L. (Johns Hopkins University School of Medicine) ; Solez, K. (University of Alberta) ; Mengel, M. (University of Alberta) ; Universitat Autònoma de Barcelona
The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications of inflammation in areas of interstitial fibrosis and tubular atrophy (i-) and its relationship to T cell-mediated rejection (), and the continued evolution of molecular diagnostics, particularly in the diagnosis of antibody-mediated rejection (). [...]
2018 - 10.1111/ajt.14625
American Journal of Transplantation, Vol. 18, Issue 2 (February 2018) , p. 293-307  
3.
14 p, 167.5 KB The Banff 2015 Kidney Meeting Report : Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology / Loupy, A. (Paris Translational Research Center for Organ Transplantation INSERM U970 & Necker Hospital University Paris Descartes) ; Haas, M. (Cedars-Sinai Medical Center) ; Solez, K. (University of Alberta) ; Racusen, L. (Johns Hopkins University School of Medicine) ; Glotz, D. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Serón Micas, Daniel (Hospital Universitari Vall d'Hebron) ; Nankivell, B. J. (Westmead Hospital) ; Colvin, R. B. (Harvard Medical School. Massachusetts General Hospital) ; Afrouzian, M. (University of Texas Medical Branch) ; Akalin, E. (Albert Einstein College of Medicine) ; Alachkar, N. (Johns Hopkins University School of Medicine) ; Bagnasco, S. (Johns Hopkins University School of Medicine) ; Becker, J. U. (University Hospital of Cologne) ; Cornell, L. (Mayo Clinic) ; Drachenberg, C. (University of Maryland School of Medicine) ; Dragun, D. (Charité Universitätsmedizin) ; de Kort, H. (Leiden University Medical Center) ; Gibson, I. W. (University of Manitoba) ; Kraus, E. S. (Johns Hopkins University School of Medicine) ; Lefaucheur, C. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Legendre, C. (Paris Translational Research Center for Organ Transplantation INSERM U970 & Necker Hospital University Paris Descartes) ; Liapis, H. (Washington University) ; Muthukumar, T. (New York Presbyterian Hospital-Weill Cornell Medicine) ; Nickeleit, V. (University of North Carolina) ; Orandi, B. (Johns Hopkins University School of Medicine) ; Park, W. (Mayo Clinic) ; Rabant, M. (Paris Translational Research Center for Organ Transplantation INSERM U970 & Necker Hospital University Paris Descartes) ; Randhawa, P. (University of Pittsburgh. The Thomas E Starzl Transplantation Institute) ; Reed, E. F. (University of California) ; Roufosse, C. (Hammersmith Hospital) ; Seshan, S. V. (Weill Cornell Medicine) ; Sis, B. (University of Alberta) ; Singh, H. K. (University of North Carolina) ; Schinstock, C. (Mayo Clinic) ; Tambur, A. (Northwestern University. Transplant Immunology Laboratory) ; Zeevi, A. (University of Pittsburgh Medical Center) ; Mengel, M. (University of Alberta) ; Universitat Autònoma de Barcelona
The Banff meeting, held in conjunction the Canadian Society of Transplantation in Vancouver, Canada, reviewed the clinical impact of updates of C4d-negative antibody-mediated rejection () from the 2013 meeting, reports from active Banff Working Groups, the relationships of donor-specific antibody tests (anti- and non-) with transplant histopathology, and questions of molecular transplant diagnostics. [...]
2017 - 10.1111/ajt.14107
American Journal of Transplantation, Vol. 17, Issue 1 (January 2017) , p. 28-41  
4.
9 p, 567.0 KB Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers : a randomized study / Espinel Garuz, Eugenia (Vall d'Hebron Hospitals) ; Joven Maried, Jorge (Universitat Rovira i Virgili) ; Gil, Iván (Vall d'Hebron Hospitals) ; Suñé, Pilar (Vall d'Hebron Hospitals) ; Renedo, Berta (Vall d'Hebron Hospitals) ; Fort Ros, Joan (Vall d'Hebron Hospitals) ; Serón Micas, Daniel (Vall d'Hebron Hospitals)
Background: Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are renoprotective but both may increase serum potassium concentrations in patients with chronic kidney disease (CKD). [...]
2013 - 10.1186/1756-0500-6-306
BMC Public health, Vol. 6, N. 306 (August 2013) , p. 1-9  

Research literature 3 records found  
1.
102 p, 5.7 MB La inflamación subclínica del injerto como modulador de la evolución del trasplante renal: repercusión a nivel inmunológico, histológico y sistémico / García Carro, Clara, autor. ; Serón Micas, Daniel, supervisor acadèmic. ; Moreso Mateos, Francesc, supervisor acadèmic. ; Fonollosa Pla, Vicent, supervisor acadèmic. ; Universitat Autònoma de Barcelona. Departament de Medicina.
El trasplante renal es el tratamiento de elección de la ERC terminal. Enlas últimas décadas, ha mejorado de manera notable la supervivenciadel paciente y del injerto a corto y medio plazo. Sin embargo, a los 10años del trasplante, el 25-35% presenta disfunción del órgano,requiriendo tratamiento dialítico. [...]
Kidney transplantation is the treatment of choice for end-stage CKD. In the last decades, graft and patient survival have dramatically improved. However, at 10 years after transplantation, 25-35% of patients present graft failures and the necessity of renal replacement therapy. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2019.  
2.
285 p, 4.1 MB Estudio exploratorio observacional y prospectivo de la maduración de la fístula arteriovenosa (FAV) nativa : estudio "MAFAVI" / Gil Carballeira, Iván, autor. ; Serón Micas, Daniel, supervisor acadèmic. ; Moreso Mateos, Francesc Josep, supervisor acadèmic. ; Vilardell, Miquel, 1946-, supervisor acadèmic. ; Universitat Autònoma de Barcelona. Departament de Medicina.
[Bellaterra] : Universitat Autònoma de Barcelona, 2017.  
3.
142 p, 1.7 MB Alteraciones de la inmunidad innata, inflamación de bajo grado y progresión de la aterosclerosis subclínica en pacientes con enfermedad renal crónica y en trasplantados renales / Azancot, María A., autor. ; Serón Micas, Daniel, supervisor acadèmic. ; Guardia Massó, Jaume, supervisor acadèmic. ; Universitat Autònoma de Barcelona. Departament de Medicina.
Introducción: La enfermedad cardiovascular se presenta de forma muy precoz en los pacientes con enfermedad renal crónica (ERC) y trasplantados renales, siendo la principal causa de mortalidad en estas poblaciones. [...]
Introduction: Cardiovascular disease is prevalent in patients with chronic kidney disease (CKD) and kidney transplants and constitutes a main cause of death in these patients. The classical cardiovascular risk factors (i. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  

See also: similar author names
1 Serón, D.R.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.